Home › Kanser sa Baga › Illinois › Joliet
Pag-aaral pangklinika para sa Kanser sa Baga sa Joliet, IL
Isang pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Joliet. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mi ang layo
- University of Chicago Medicine-Orland Park, Orland Park · 14 mi ang layo
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Nagre-recruitPhase 3
- Northwestern Medicine Orland Park, Orland Park · 14 mi ang layo
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Nagre-recruitPhase 3
- Northwestern Medicine Orland Park, Orland Park · 14 mi ang layo
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Nagre-recruitPhase 2
- Hope and Healing Clinical Research, New Lenox · 6 mi ang layo
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Hope and Healing Cancer Services, New Lenox · 6 mi ang layo
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Nagre-recruitPhase 3
- Hope and Healing Cancer Services, New Lenox · 6 mi ang layo
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Nagre-recruitPhase 2
- Hope and Healing Clinical Research, New Lenox · 6 mi ang layo
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Nagre-recruitPhase 1/2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mi ang layo
- University of Chicago Medicine-Orland Park, Orland Park · 14 mi ang layo
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- University of Chicago, New Lenox · 6 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi ang layo
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Northwestern Medicine Orland Park, Orland Park · 14 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi ang layo
Pag-aaral para sa Kanser sa Baga sa ibang lungsod
- Houston, TX78 pag-aaral
- Boston, MA62 pag-aaral
- New York City, NY60 pag-aaral
- Los Angeles, CA45 pag-aaral
- Arlington, VA41 pag-aaral
- Washington, DC41 pag-aaral
- Chicago, IL41 pag-aaral
- Nashville, TN40 pag-aaral
- Baltimore, MD40 pag-aaral
- St. Louis, MO39 pag-aaral
- Columbus, OH37 pag-aaral
- Philadelphia, PA36 pag-aaral
Iba pang pag-aaral sa Joliet
- Non-Small Cell Lung Cancer12 pag-aaral
- Kanser sa Pantog7 pag-aaral
- Metastatic Cancer7 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Kanser sa Prostate5 pag-aaral
- Acute Myeloid Leukemia5 pag-aaral
- Kanser ng Hipoparynk5 pag-aaral
- Kanser sa Larynx5 pag-aaral
- Kanser sa Bibig5 pag-aaral
- Kanser sa Suso4 pag-aaral
- Kanser sa Ovary4 pag-aaral
- Colon Cancer4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.